课题基金 / 基金详情

Planning the VICTORY (VIsual ComplicaTions Of PrematuRitY) Study

Planning the VICTORY (VIsual ComplicaTions Of PrematuRitY) Study
规划 VICTORY(早产儿视觉并发症)研究
批准号:
10645471
负责人:
Olaf Dammann
金额:
$31.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2025-05-31

项目摘要

项目成果

Olaf Dammann的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
PROJECT SUMMARY Retinopathy of prematurity (ROP) is a neurovascular disorder that occurs mainly among extremely preterm infants. The National Eye Institute (NEI) estimates that every year between 400 and 600 children become legally blind due to ROP. The goal of this project is to plan a large, multicenter cohort study designed to gather comprehensive social, clinical, and biomarker data needed to further elucidate the etiology and pathogenesis of ROP and adverse visual outcomes (AVO) in extremely low gestational age newborns (ELGANs, <28weeks gestation). The aims of the project are (1) to finalize the consortium and create expert working groups (WGs) that will tackle the planning tasks in their area of expertise, (2) to develop the study protocol and Manual of Procedures (MOP), and (3) to outline and perform preliminary and feasibility studies. The planned study will have multiple innovative elements, the most important being (a) first multicenter observational study with a focus on ROP/AVO, (b) retina imaging at multiple timepoints after birth, (c) artificial intelligence/machine learning approaches, (d) social determinants of health, (e) pre- and postnatal biomarker measurements, and (f) visual and neurodevelopmental outcome assessment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Circulating Immune Biomarkers and Retinopathy of Prematurity
  • 批准号:
    8610316
  • 项目类别:
  • 资助金额:
    $48.52万
  • 财政年份:
    2013
  • 负责人:
    Olaf Dammann
  • 依托单位:
Circulating Immune Biomarkers and Retinopathy of Prematurity
  • 批准号:
    8798664
  • 项目类别:
  • 资助金额:
    $40.88万
  • 财政年份:
    2013
  • 负责人:
    Olaf Dammann
  • 依托单位:
Circulating Immune Biomarkers and Retinopathy of Prematurity
  • 批准号:
    8373245
  • 项目类别:
  • 资助金额:
    $54.94万
  • 财政年份:
    2013
  • 负责人:
    Olaf Dammann
  • 依托单位:
Circulating Immune Biomarkers and Retinopathy of Prematurity
  • 批准号:
    9018025
  • 项目类别:
  • 资助金额:
    $26.71万
  • 财政年份:
    2013
  • 负责人:
    Olaf Dammann
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: